699
Participants
Start Date
August 1, 2017
Primary Completion Date
September 15, 2020
Study Completion Date
September 15, 2020
CRT-D
Commercially approved quadripolar Boston Scientific Cardiac Resynchronization Therapy Defibrillator (CRT-D) devices and future generations of BSC X4 CRT-D devices approved by the appropriate regulatory bodies will be included in the trial. All devices utilized in the study will include SmartDelay™ and must be capable of providing SmartDelay recommendations for both biventricular pacing (BiV) and Left Ventricular (LV) only pacing. All enrolled subjects with implanted BSC X4 CRT-D system and identified with an RV-LV delay of ≥70ms were 1:1 randomized. Randomization occurred in the electronic data capturing system.
New York Methodist Hospital, Brooklyn
Unfalkrankenhaus Marzahn, Berlin
University of Berlin, Charite Virchow Standort, Berlin
Centre hospitalier du pays d'Aix, Aix-en-Provence
Geisinger Clinic, Danville
University of Pennsylvania, Philadelphia
Pottstown Medical Specialist, Inc, Pottstown
Christiana Care Health Services, Newark
Virginia Commonwealth University Medical Center, Richmond
Novant Health Forsyth Medical Center, Winston-Salem
Hospital 12 de Octubre Madrid, Madrid
Novant Health Heart and Vascular Institute, Charlotte
Medical University of South Carolina, Charleston
Emory University Hospital, Atlanta
Northside Hospital, Atlanta
Centre Hôpital Universitaire Rangueil, Toulouse
Baptist Health Research Institute, Jacksonville
Watson Clinic Center for Research, Inc, Lakeland
Winter Haven Hospital, Winter Haven
Azienda Sanitaria Universtitaria Integrata di Trieste, Trieste
CHRU Hopital Pontchaillou, Rennes
Affinity Hospital, LLC d/b/a Granview Medical Center, Birmingham
Heart Center Research LLC, Huntsville
CHU Grenoble, Grenoble
Otto-von-Guericke-Universitaet Magdeburg, Magdeburg
Ospedale S. Orsola - Malpighi, Bologna
Baptist Health Lexington, Lexington
St. Elizabeth Healthcare, Edgewood
The Ohio Health Research Institute- Grant Medical Center, Columbus
Hospital Universitario La Fe, Valencia
Heart Group at Deaconness Hospital, Newburgh
Cardiovascular Institute of Michigan, Roseville
Trinity Health Michigan d/b/a Michigan Heart, Ypsilanti
University of Iowa Hospitals, Iowa City
HealthEast St. Joseph's Hospital, Saint Paul
North Central Heart, Sioux Falls
CHRU de Lille, Lille
Hopital Saint Philibert, Lille
The International Heart Institute on Montana Foundation, Missoula
The University of Chicago, Chicago
St. John's Hospital, Springfield
Cardiology Associates of NE Arkansas, Jonesboro
Dallas VA Research Corporation, Dallas
Centre Hôpital Universitaire Rouen, Hôpital Charles Nicolle, Rouen
Michael E. DeBakey VA Medical Center, Houston
Foundation for Advancing Veterans' Health Research, San Antonio
Krankenhaus Landshut-Achdorf, Landshut
University of Arizona Sarver Heart Center, Tucson
Glendale Adventist Medical Center, Glendale
Salinas Valley Memorial Healthcare System, Salinas
Providence Heart Institute, Portland
PeaceHealth Southwest Medical Center, Vancouver
Lahey Hospital and Medical Center, Burlington
Southcoast Health, Fall River
Cardiovascular Associates of the Delaware Valley, Haddon Heights
The Valley Hospital, Paramus
Institut universitaire de Cardiologie et de Pneumologie de Quebec, Québec
Shinshu University Hospital, Nagano
Uni Jena, Jena
Mater Misericordiae University Hospital, Dublin
Hirosaki University Hospital, Hirosaki-shi
Hiroshima Prefectural Hospital, Hiroshima
Tokyo Medical University Hospital, Shinjuku-Ku
St. Antonius Ziekenhuis, Nieuwegein
Hospital Infanta Cristina, Badajoz
Cardiocentro Ticino, Lugano
Royal Sussex County Hospital, Brighton
University Hospital of Wales, Cardiff
Hammersmith Hospital, London
Freeman Hospital, Newcastle upon Tyne
Nottingham University Hospital, Nottingham
Southampton University Hospital, Southampton
Lead Sponsor
Boston Scientific Corporation
INDUSTRY